Human Health Innovation

Boehringer Ingelheim is clear about its goals. We want to deliver a portfolio of breakthrough medicines that will improve the lives of patients around the word. That starts with innovation.

human scientist
Drug Discovery Human Health

Research and Development Pipeline

With a pipeline of around 100 clinical and pre-clinical projects, and the potential to deliver up to 15 new medicine approvals by 2025, we continue our track record of long-term innovation-led performance.

Drug Discovery Process

From initial discovery to a marketable medicine is a long, challenging road. On average, from more than a million screened molecules only one is investigated in late stage clinical trials and is finally made available for patients.

hero Pressebild_Boehringer_Ingelheim